LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tomatoes in Diet Protect Mice from Skin Cancer

By LabMedica International staff writers
Posted on 31 Jul 2017
Image: Lycopene, the antioxidant red pigment that colors tomatoes (Photo courtesy of Wikimedia Commons).
Image: Lycopene, the antioxidant red pigment that colors tomatoes (Photo courtesy of Wikimedia Commons).
Cancer researchers working with a mouse model showed that a diet supplemented with tomatoes could protect against skin cancer.

Based on previous studies that had found that prolonged tomato consumption could mitigate ultraviolet (UV) light induced sunburn via unknown mechanisms, investigators at Ohio State University (Columbus, USA) hypothesized that tomato consumption would protect against skin cancer.

To test this theory, the investigators fed diets supplemented with 10% tangerine or red tomato powder to a population of SKH-1 hairless and immunocompetent mice for 35 weeks. From weeks 11 to 20, the mice were exposed to UV light, three times per week, and tumors were tracked weekly. Control mice were fed the same diets but not exposed to UV light.

Results published in the July 11, 2017, online edition of the journal Scientific Reports revealed that significantly fewer tumors developed in male mice consuming red tomato diets or pooled tomato diets compared to controls. Carotenoid levels in plasma and skin were quantitated, with total lycopene higher in skin of tangerine fed animals despite a lower dose. Lycopene, the primary carotenoid in tomatoes, has been shown to be the most effective antioxidant of these pigments.

Metabolomic analyses elucidated compounds derived from tomato glycoalkaloids (including tomatidine and hydroxylated-tomatidine) as significantly different metabolites in skin after tomato supplementation.

Results showing that there were no significant differences in tumor number for female mice in the study confirmed previous findings that male mice developed tumors earlier after UV exposure and that their tumors are more numerous, larger, and more aggressive.

"This study showed us that we do need to consider sex when exploring different preventive strategies," said senior author Dr. Tatiana Oberyszyn, professor of pathology at Ohio State University. "What works in men may not always work equally well in women and vice versa."

Related Links:
Ohio State University

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Hybrid Pipette
SWITCH

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more